BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26829364)

  • 1. Stimulatory effect of an algal fucoidan on the release of vascular endothelial tissue-type plasminogen activator as a mechanism of fucoidan-mediated thrombolysis.
    Min SK; Han SM; Jang JS; Kim JK
    Blood Coagul Fibrinolysis; 2016 Jul; 27(5):594-6. PubMed ID: 26829364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Algal fucoidan, unlike heparin, has thrombolytic activity in a murine arterial thrombosis model.
    Min SK; Han SM; Kim HT; Kwon OC; Lee S; Kim JK
    Blood Coagul Fibrinolysis; 2012 Jul; 23(5):359-66. PubMed ID: 22576287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An antithrombotic fucoidan, unlike heparin, does not prolong bleeding time in a murine arterial thrombosis model: a comparative study of Undaria pinnatifida sporophylls and Fucus vesiculosus.
    Min SK; Kwon OC; Lee S; Park KH; Kim JK
    Phytother Res; 2012 May; 26(5):752-7. PubMed ID: 22084059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolytic fucoidans inhibit the tPA-PAI1 complex, indicating activation of plasma tissue-type plasminogen activator is a mechanism of fucoidan-mediated thrombolysis in a mouse thrombosis model.
    Choi Y; Min SK; Usoltseva R; Silchenko A; Zvyagintseva T; Ermakova S; Kim JK
    Thromb Res; 2018 Jan; 161():22-25. PubMed ID: 29178986
    [No Abstract]   [Full Text] [Related]  

  • 5. Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo.
    Ueshima S; Matsuno H; Hayashi M; Horibuchi K; Okada K; Fukao H; Uematsu T; Matsuo O
    Thromb Haemost; 2002 Jun; 87(6):1069-74. PubMed ID: 12083488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
    J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bolus dose response characteristics of single chain urokinase plasminogen activator and tissue plasminogen activator in a dog model of arterial thrombosis.
    Badylak SF; Voytik S; Klabunde RE; Henkin J; Leski M
    Thromb Res; 1988 Nov; 52(4):295-312. PubMed ID: 3144052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mouse dorsal skinfold chamber as a model for the study of thrombolysis by intravital microscopy.
    Boulaftali Y; Lamrani L; Rouzaud MC; Loyau S; Jandrot-Perrus M; Bouton MC; Ho-Tin-Noé B
    Thromb Haemost; 2012 May; 107(5):962-71. PubMed ID: 22552380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid selectively increases vascular endothelial tissue-type plasminogen activator production and reduces thrombus formation in the mouse.
    Larsson P; Alwis I; Niego B; Sashindranath M; Fogelstrand P; Wu MC; Glise L; Magnusson M; Daglas M; Bergh N; Jackson SP; Medcalf RL; Jern S
    J Thromb Haemost; 2016 Dec; 14(12):2496-2508. PubMed ID: 27706906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural characterization and anti-thrombotic properties of fucoidan from Nemacystus decipiens.
    Cui K; Tai W; Shan X; Hao J; Li G; Yu G
    Int J Biol Macromol; 2018 Dec; 120(Pt B):1817-1822. PubMed ID: 30223052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of plasminogen activator inhibitor-1 accelerates thrombolysis of a platelet-rich thrombus in rat mesenteric arterioles.
    Rupin A; Martin F; Vallez MO; Bonhomme E; Verbeuren TJ
    Thromb Haemost; 2001 Dec; 86(6):1528-31. PubMed ID: 11776323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic combinations of recombinant human tissue-type plasminogen activator and human single-chain urokinase-type plasminogen activator. Effect on thrombolysis and reocclusion in a canine coronary artery thrombosis model with high-grade stenosis.
    Ziskind AA; Gold HK; Yasuda T; Kanke M; Guerrero JL; Fallon JT; Saito T; Collen D
    Circulation; 1989 Feb; 79(2):393-9. PubMed ID: 2492455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolytic and anticoagulant activities of highly sulfated fucoidan.
    Soeda S; Sakaguchi S; Shimeno H; Nagamatsu A
    Biochem Pharmacol; 1992 Apr; 43(8):1853-8. PubMed ID: 1533520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of the stimulatory effect of native fucoidan, highly sulfated fucoidan and heparin on plasminogen activation by tissue plasminogen activator: the role of chloride.
    Lang D; Williams T; Phillips A; Doctor VM
    Eur J Drug Metab Pharmacokinet; 2004; 29(4):269-75. PubMed ID: 15726889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-targeting fucoidan-based microvesicle for arterial thrombolysis and re-occlusion inhibition.
    Chen Z; Yuan C; Ye Y; Lu B; Hu E; Lu F; Yu K; Xie R; Lan G
    Carbohydr Polym; 2024 Mar; 328():121703. PubMed ID: 38220339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated transfer of tissue-type plasminogen activator augments thrombolysis in tissue-type plasminogen activator-deficient and plasminogen activator inhibitor-1-overexpressing mice.
    Carmeliet P; Stassen JM; Van Vlaenderen I; Meidell RS; Collen D; Gerard RD
    Blood; 1997 Aug; 90(4):1527-34. PubMed ID: 9269770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-metastasis effect of fucoidan from Undaria pinnatifida sporophylls in mouse hepatocarcinoma Hca-F cells.
    Wang P; Liu Z; Liu X; Teng H; Zhang C; Hou L; Zou X
    PLoS One; 2014; 9(8):e106071. PubMed ID: 25162296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of tissue-type plasminogen activator synthesis by retinoids in cultured human endothelial cells and rat tissues in vivo.
    Kooistra T; Opdenberg JP; Toet K; Hendriks HF; van den Hoogen RM; Emeis JJ
    Thromb Haemost; 1991 May; 65(5):565-72. PubMed ID: 1908141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolytic properties of human tissue-type plasminogen activator, single-chain urokinase-type plasminogen activator, and synergistic combinations in venous thrombosis models in dogs and rabbits.
    Spriggs DJ; Stassen JM; Hashimoto Y; Collen D
    Blood; 1989 Apr; 73(5):1207-12. PubMed ID: 2495034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.